The effect of different digoxin concentrations on heart tissue and antioxidant status in iron-overloaded rats

ARYA Atherosclerosis

Volumn 14, Issue 2, 2018, Pages 46-52

  Shahouzehi, Beydolah ^a   Nasri, Hamid Reza ^b   Masoumi Ardakani, Yaser ^c  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Digoxin; Glutathione peroxidase; Iron overload; Superoxide dismutase

Indexed keywords

CALCIUM; DIGOXIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; IRON DEXTRAN; MALONALDEHYDE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ANTIOXIDANT ASSAY; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DIGOXIN BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FERRITIN BLOOD LEVEL; HEART FAILURE; HEART TISSUE; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; LIPID PEROXIDATION; MALE; NONHUMAN; PREVALENCE; RAT; THALASSEMIA MAJOR; TOTAL ANTIOXIDANT STATUS;

EID: 85049076483     PISSN: 17353955     EISSN: 22516638     Source Type: Journal    
DOI: 10.22122/arya.v14i2.1642     Document Type: Article

References (30)

1. Bhagat S, Sarkar PD, Suryakar AN, Hundekar PS. A study on the biomarkers of oxidative stress: The effects of oral therapeutic supplementation on the iron concentration and the product of lipid peroxidation in beta thalassemia major. J Clin Diagn Res 2012; 6(7): 1144-7.
2. Khodaei GH, Farbod N, Zarif B, Nateghi S, Saeidi M. Frequency of thalassemia in Iran and Khorasan Razavi. Int J Pediatr 2013; 1(1): 45-50.
3. 2+ and Cu+ with dioxygen; Comparison with the Fenton chemistry. Acta Biochim Pol 2000; 47(4): 951-62.
4. Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M, Madden J, et al. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol 2006; 135(2): 254-63.
5. Gao X, Campian JL, Qian M, Sun XF, Eaton JW. Mitochondrial DNA damage in iron overload. J Biol Chem 2009; 284(8): 4767-75.
6. Handa P, Morgan-Stevenson V, Maliken BD, Nelson JE, Washington S, Westerman M, et al. Iron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to nonalcoholic steatohepatitis in genetically obese mice. Am J Physiol Gastrointest Liver Physiol 2016; 310(2): G117-G127.
7. Kuo KL, Hung SC, Lee TS, Tarng DC. Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD. J Am Soc Nephrol 2014; 25(11): 2596-606.
8. Gammella E, Recalcati S, Rybinska I, Buratti P, Cairo G. Iron-induced damage in cardiomyopathy: Oxidative-dependent and independent mechanisms. Oxid Med Cell Longev 2015; 2015: 230182.
9. Engle MA, Erlandson M, Smith CH. Late cardiac complications of chronic, severe, refractory anemia with hemochromatosis. Circulation 1964; 30:698-705.
10. Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, et al. Survival and causes of death in thalassaemia major. Lancet 1989; 2(8653): 27-30.
11. Ladis V, Chouliaras G, Berdousi H, Kanavakis E, Kattamis C. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Ann N Y Acad Sci 2005; 1054: 445-50.
12. Kremastinos DT, Farmakis D, Aessopos A, Hahalis G, Hamodraka E, Tsiapras D, et al. Beta-thalassemia cardiomyopathy: History, present considerations, and future perspectives. Circ Heart Fail 2010; 3(3): 451-8.
13. Leliévre LG, Lechat P. Mechanisms, manifestations, and management of digoxin toxicity. Heart Metab 2007; 35: 9-11.
14. Kurian M. The effect of digitalis on the heart-an update. J Pharm Sci Res 2015; 7(10): 861-3.
15. Tsushima RG, Wickenden AD, Bouchard RA, Oudit GY, Liu PP, Backx PH. Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: Possible implications in iron overload. Circ Res 1999; 84(11): 1302-9.
16. 2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 2003; 9(9): 1187-94.
17. Kumfu S, Chattipakorn S, Chinda K, Fucharoen S, Chattipakorn N. T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice. Eur J Haematol 2012; 88(6): 535-48.
18. Chattipakorn N, Kumfu S, Fucharoen S, Chattipakorn S. Calcium channels and iron uptake into the heart. World J Cardiol 2011; 3(7): 215-8.
19. Chen MP, Cabantchik ZI, Chan S, Chan GC, Cheung YF. Iron overload and apoptosis of HL-1 cardiomyocytes: Effects of calcium channel blockade. PLoS One 2014; 9(11): e112915.
20. Kumfu S, Chattipakorn SC, Fucharoen S, Chattipakorn N. Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice. Exp Physiol 2016; 101(4): 521-39.
21. Nasri HR, Shahouzehi B, Masoumi-Ardakani Y, Iranpour M. Effects of digoxin on cardiac iron content in rat model of iron overload. ARYA Atheroscler 2016; 12(4): 180-4.
22. Lim CS, Vaziri ND. The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure. Kidney Int 2004; 65(5): 1802-9.
23. Wood JC, Enriquez C, Ghugre N, Otto-Duessel M, Aguilar M, Nelson MD, et al. Physiology and pathophysiology of iron cardiomyopathy in thalassemia. Ann N Y Acad Sci 2005; 1054: 386-95.
24. Mishra AK, Tiwari A. Iron overload in Beta thalassaemia major and intermedia patients. Maedica (Buchar) 2013; 8(4): 328-32.
25. Sattari M, Sheykhi D, Nikanfar A, Pourfeizi AH, Nazari M, Dolatkhah R, et al. The financial and social impact of thalassemia and its treatment in Iran. Pharm Sci 2012; 18(3): 171-6.
26. Kumfu S, Chattipakorn S, Srichairatanakool S, Settakorn J, Fucharoen S, Chattipakorn N. T-type calcium channel as a portal of iron uptake into cardiomyocytes of beta-thalassemic mice. Eur J Haematol 2011; 86(2): 156-66.
27. Kumfu S, Chattipakorn S, Fucharoen S, Chattipakorn N. Ferric iron uptake into cardiomyocytes of b-thalassemic mice is not through calcium channels. Drug Chem Toxicol 2013; 36(3): 329-34.
28. Arispe N, Diaz JC, Simakova O, Pollard HB. Heart failure drug digitoxin induces calcium uptake into cells by forming transmembrane calcium channels. Proc Natl Acad Sci U S A 2008; 105(7): 2610-5.
29. de Valk B, Marx JJ. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med 1999; 159(14): 1542-8.
30. Lee TS, Shiao MS, Pan CC, Chau LY. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation 1999; 99(9): 1222-9.